★ Daily Intelligence Briefings (DIBs)Biotechnology & HealthcareⓁ PharmaceuticalsMarkets Big Pharma Set to Let Biotech Bleed Continue Before Deploying Massive Cash Balances Throughout the past few months, MRP has highlighted significant cash balances among many biopharmaceutical giants. Though hundreds of billions of dollars…McAlinden Research PartnersJune 14, 2022
★ Daily Intelligence Briefings (DIBs)Biotechnology & HealthcareMarkets Biotech, Pharma Cash Piles set to Drive Dealmaking and Buyback Activity in 2022 Most data indicates M&A activity has slowed in the pharmaceutical and biotech industries. However, that may change in 2022 as…McAlinden Research PartnersDecember 22, 2021
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerServicesTechnology Cybersecurity Stocks on the Rise as IPOs, M&A, and VC Funding Ratchet Up New attacks on Microsoft's cloud and Azure services throughout the last month underscore a continually rising volume of cyberattacks. These,…McAlinden Research PartnersNovember 2, 2021
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerFinanceMarketsMonetary Policy US Banks Capitalize on Increased Dealmaking, New Limits on Financial Sector Consolidation Linger US Banks are setting up for another strong year as they continue to rake in impressive revenues, bolstered by an ongoing wave of…McAlinden Research PartnersJuly 19, 2021